Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schraml

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Der Pathologe|October 29, 2009
[Identification of VHL-associated changes in clear cell renal carcinoma: the application of combined genome and expression analyses]G Boysen, B Wollscheid, D Bausch-Fluck, et al.
Schweizerische Medizinische Wochenschrift|June 1, 2000
Identification of genes differentially expressed in melanoma sublines derived from a single surgical specimen characterised by different sensitivity to cytotoxic T-lymphocyte activityT Kocher, P Schraml, G C Spagnoli, et al.
Human Genetics|June 1, 1993
Loss of heterozygosity on chromosome 11p13 in primary bladder carcinomaR Shipman, P Schraml, M Colombi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Frequent TP53 gene alterations (mutation, allelic loss, nuclear accumulation) in primary non-small cell lung cancerR Shipman, P Schraml, M Colombi, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|November 27, 2007
[mRNA expression analysis of metastatic markers in clear-cell renal cell carcinoma]K Struckmann, K Mertz, P Staller, et al.
International Journal of Oncology|May 3, 2011
p53 protein accumulation and p53 gene alterations (RFLP, VNTR and p53 gene mutations) in non-invasive versus invasive human transitional bladder cancerR Shipman, P Schraml, H Moch, et al.
Gut|April 16, 2005
Biologics in inflammatory disease: infliximab associated risk of lymphoma developmentC Bucher, L Degen, S Dirnhofer, et al.
British Journal of Cancer|December 12, 2013
Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expressionL Wyler, C U Napoli, B Ingold, et al.
The Journal of Pathology|March 4, 2000
Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinomaP Schraml, D Müller, R Bednar, et al.
The Journal of Pathology|January 15, 2008
pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinomaK Struckmann, Kd Mertz, S Steu, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Der Pathologe|October 29, 2009
[Identification of VHL-associated changes in clear cell renal carcinoma: the application of combined genome and expression analyses]G Boysen, B Wollscheid, D Bausch-Fluck, et al.
Schweizerische Medizinische Wochenschrift|June 1, 2000
Identification of genes differentially expressed in melanoma sublines derived from a single surgical specimen characterised by different sensitivity to cytotoxic T-lymphocyte activityT Kocher, P Schraml, G C Spagnoli, et al.
Human Genetics|June 1, 1993
Loss of heterozygosity on chromosome 11p13 in primary bladder carcinomaR Shipman, P Schraml, M Colombi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Frequent TP53 gene alterations (mutation, allelic loss, nuclear accumulation) in primary non-small cell lung cancerR Shipman, P Schraml, M Colombi, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|November 27, 2007
[mRNA expression analysis of metastatic markers in clear-cell renal cell carcinoma]K Struckmann, K Mertz, P Staller, et al.
International Journal of Oncology|May 3, 2011
p53 protein accumulation and p53 gene alterations (RFLP, VNTR and p53 gene mutations) in non-invasive versus invasive human transitional bladder cancerR Shipman, P Schraml, H Moch, et al.
Gut|April 16, 2005
Biologics in inflammatory disease: infliximab associated risk of lymphoma developmentC Bucher, L Degen, S Dirnhofer, et al.
British Journal of Cancer|December 12, 2013
Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expressionL Wyler, C U Napoli, B Ingold, et al.
The Journal of Pathology|March 4, 2000
Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinomaP Schraml, D Müller, R Bednar, et al.
The Journal of Pathology|January 15, 2008
pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinomaK Struckmann, Kd Mertz, S Steu, et al.
Pageof 6